Beijing Foyou Pharma Co., Ltd.SSE: 601089

Announcement on Obtaining Drug Registration Certificate for Clopidogrel Aspirin Tablets

· Issued by Beijing Foyou Pharma Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

Beijing Foyou Pharma Co., Ltd. has announced that it has received a drug registration certificate for Clopidogrel Aspirin Tablets from the National Medical Products Administration. The certificate allows the company to produce this medication, which is indicated for secondary prevention of atherosclerotic thrombotic events. The announcement highlights the potential impact on the company's product line and market competitiveness, while also noting the uncertainties in sales due to regulatory and market factors.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Obtaining Drug Registration Certificate for Clopidogrel Aspirin Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Beijing Foyou Pharma Co., Ltd. on 6ix

Earlier from Beijing Foyou Pharma

Later from Beijing Foyou Pharma

All Beijing Foyou Pharma news releases